R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, FASCO

R. Donald Harvey, PharmD, is Professor in the Department of Hematology and Medical Oncology with a joint appointment in the Department of Pharmacology and Chemical Biology at Emory University School of Medicine. A board certified oncology pharmacist, Dr. Harvey serves as director of Winship Cancer Institute's Phase I Clinical Trials Unit. He formerly served as Medical Director of Winship's Clinical Trials Office, where he worked to ensure the quality and compliance of clinical research practices at all Winship locations. He is a Fellow of the American College of Clinical Pharmacy, a Fellow of the Hematology/Oncology Pharmacy Association and a Fellow of the American Society of Clinical Oncology.

Dr. Harvey has established an active clinical pharmacology research program in cancer at Emory with the goal of using pharmacokinetic, pharmacodynamic, and other tools to improve individualization of therapy and clinical outcomes. An active principal and co-investigator on multiple trials, he also consults on experimental design of preclinical and clinical studies with a focus on optimizing correlative measures. Specific areas of research interest include agent tolerability and disposition in renal and hepatic impairment, effects of novel immunotherapeutics on hepatic metabolism, and use of therapeutic drug monitoring for anticancer agents.

Dr. Harvey is also active nationally and internationally in several cancer and pharmacology professional organizations. He is also a past president of the Hematology and Oncology Pharmacy Association, an international professional organization.